Capricor Therapeutics, Inc. (CAPR) by event type
CAPR moves most on analyst upgrades — a median of -3.80% at 30 minutes across 18 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the CAPR overview →
How CAPR reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,713 of 2,717 | 18 | -3.80% | 33% | -4.34% |
| Analyst downgrades 1,818 of 2,603 | 23 | -0.16% | 30% | +35.60% |
| Coverage initiations 1,543 of 2,283 | 19 | -0.12% | 37% | +1.60% |
| Rating reiterations 2,788 of 3,522 | 88 | -0.15% | 43% | -0.14% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how CAPR usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · CAPR overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Novo Nordisk A/S (NVO) | 1,909 | 0.00% | 50% |
| CELGENE (CELG) | 1,880 | +0.03% | 52% |
| Spectrum Pharmaceuticals, Inc. (SPPI) | 1,780 | 0.00% | 48% |
| Cytokinetics, Incorporated (CYTK) | 1,706 | +0.02% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.